UK

Sarepta shares slide again as drugmaker bows to FDA pressure to pause gene therapy

Jul 22, 2025 - 15:52
 0  0
Sarepta shares slide again as drugmaker bows to FDA pressure to pause gene therapy
Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that have attracted attention from regulators
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0

Related Posts

Dubai flights cancelled and diverted after US strikes on Iran

Dubai flights cancelled and diverted after US strikes o...

Jun 22, 2025  0  0

For sure – Marcus Rashford would relish playing with Lamine Yamal at Barcelona

For sure – Marcus Rashford would relish playing with La...

Jun 22, 2025  0  0

Sir Chris Hoy backs calls for overhaul of prostate cancer screenings

Sir Chris Hoy backs calls for overhaul of prostate canc...

Jun 22, 2025  0  0

Transfer news live: Liverpool sell Quansah, Bayern battle Chelsea for Gittens, Arsenal’s Rodrygo hurdle

Transfer news live: Liverpool sell Quansah, Bayern batt...

Jun 22, 2025  0  0

Animal welfare concerns halt hotel’s panda wake-up service

Animal welfare concerns halt hotel’s panda wake-up service

Jun 22, 2025  0  0

Fred Smith: FedEx founder who revolutionised delivery business dies aged 80

Fred Smith: FedEx founder who revolutionised delivery b...

Jun 22, 2025  0  0